Guilford Jacquelyn M, Pezzuto John M
University of Hawaii at Hilo, College of Pharmacy, 34 Rainbow Drive, Hilo, Hawaii 96720, USA.
Expert Opin Investig Drugs. 2008 Sep;17(9):1341-52. doi: 10.1517/13543784.17.9.1341.
Although carcinogenesis and cancer have been studied intensively for > 50 years, the rates of cancer incidence and mortality remain high. The most successful approach for reducing these rates has been primary prevention. For individuals at a high risk of developing cancer owing to certain genetic, environmental and occupational factors, cancer chemoprevention is a logical approach.
This review discusses natural products as inhibitors of carcinogenesis.
Natural product chemopreventive agents are inherently biologically active and have been demonstrated to prevent and reverse the carcinogenic process in a pleiotropic manner. Derivatives of compounds discovered by screening natural products for chemopreventive agents have shown efficacy in clinical trials. Despite the obstacles that must be overcome before chemopreventive drugs become an integral component of standard medical practice for cancer prophylaxis, there is vast potential for significant improvement in cancer morbidity and mortality through the use of natural product chemopreventive drugs.
尽管对致癌作用和癌症的研究已深入开展了50多年,但癌症的发病率和死亡率仍然很高。降低这些比率最成功的方法是一级预防。对于因某些遗传、环境和职业因素而具有高患癌风险的个体,癌症化学预防是一种合理的方法。
本综述讨论天然产物作为致癌作用抑制剂的情况。
天然产物化学预防剂具有内在的生物活性,并已被证明能以多效性方式预防和逆转致癌过程。通过筛选天然产物寻找化学预防剂而发现的化合物衍生物已在临床试验中显示出疗效。尽管在化学预防药物成为癌症预防标准医疗实践的一个组成部分之前必须克服诸多障碍,但使用天然产物化学预防药物在显著改善癌症发病率和死亡率方面具有巨大潜力。